跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Dihydrogenphosphate
首页
药物
Dihydrogenphosphate
Experimental
Small Molecule
Dihydrogenphosphate
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
技术标识符
化学式
H
2
O
4
P
CAS 编号
29505-79-1
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
PHARMACEUTICAL PREPARATIONS CONTAINING AMINOBENZENE-SULFONIC ACID DERIVATIVES AS THE ACTIVE INGREDIENT
EP 1419775 A1
申请人: MITSUBISHI PHARMA CORP
优先权: 2001
EP
US
2 件公开
Phosphoric acid salt of a dipeptidyl peptidase-IV inhibitor
US 7326708 B2
申请人: MERCK & CO INC
优先权: 2004
US
2 件公开
Amorphous Form of a Phosphoric Acid Salt of a Dipeptidyl Peptidase-IV Inhibitor
US 2007281941 A1
申请人: FERLITA RUSSELL R
优先权: 2005
US
2 件公开
Carvedilol phosphate sesquihydrate
US 8344159 B2
申请人: MYLAN LAB LTD
优先权: 2006
US
2 件公开
Novel Polymorphic Forms of 6-(1-methyl-1H-pyrazol-4-yl)-2--2H-pyridazin-3-one Dihydrogenphosphate and Processes of Manufacturing thereof
US 2011257180 A1
申请人: MERCK PATENT GMBH
优先权: 2008
US
2 件公开
Antiviral 6-{2-[1-(6-methyl-3-pyridazinyl)-4-piperidinyl]ethoxy}-3-ethoxy-1,2-benzisoxazole bis-dihydrogen-phosphate salts
US 8580791 B2
申请人: RYAN JANE
优先权: 2009
US
2 件公开
DOSAGE FORM PROVIDING PROLONGED RELEASE OF TAPENTADOL PHOSPHORIC ACID SALT
EP 3875079 A1
申请人: GRUENENTHAL GMBH
优先权: 2020
EP
2 件公开
Alpha-amylase activity inhibitors
US 2003124208 A1
申请人: MAKINO TAKASHI
优先权: 2000
US
Bioreductively activated stilbene prodrugs
US 2006223827 A1
申请人: SIEMENS AG
优先权: 2003
US
Novel crystalline forms of a phosphoric acid salt of a dipeptidyl peptidase-iv inhibitor
US 2006287528 A1
申请人: WENSLOW ROBERT M
优先权: 2006
US
第 1 / 2 页
上一页
下一页
药物
反馈